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ABSTRACT
Objective: In the context of patient broad consent for future research uses of their identifiable health record
data, we compare the effectiveness of interactive trust-enhanced e-consent, interactive-only e-consent, and
standard e-consent (no interactivity, no trust enhancement).
Materials and Methods: A randomized trial was conducted involving adult participants making a scheduled pri-
mary care visit. Participants were randomized into 1 of the 3 e-consent conditions. Primary outcomes were
patient-reported satisfaction with and subjective understanding of the e-consent. Secondary outcomes were
objective knowledge, perceived voluntariness, trust in medical researchers, consent decision, and time spent
using the application. Outcomes were assessed immediately after use of the e-consent and at 1-week follow-up.
Results: Across all conditions, participants (N¼734) reported moderate-to-high satisfaction with consent (mean
4.3 of 5) and subjective understanding (79.1 of 100). Over 94% agreed to share their health record data. No
statistically significant differences in outcomes were observed between conditions. Irrespective of condition,
black participants and those with lower education reported lower satisfaction, subjective understanding, knowl-
edge, perceived voluntariness, and trust in medical researchers, as well as spent more time consenting.
Conclusions: A large majority of patients were willing to share their identifiable health records for research, and
they reported positive consent experiences. However, incorporating optional additional information and mes-
sages designed to enhance trust in the research process did not improve consent experiences. To improve
poorer consent experiences of racial and ethnic minority participants and those with lower education, other
novel consent technologies and processes may be valuable. (An Interactive Patient-Centered Consent for Re-
search Using Medical Records; NCT03063268)
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INTRODUCTION
The widespread implementation of electronic health record (EHR)
systems in the United States has created new opportunities for re-
search data repositories,1–3 quality assurance,4,5 targeted research
recruitment,6 and cross-institutional data sharing networks such as
the Patient-Centered Outcomes Research Network (PCORnet).7,8 In
addition, recent updates to the Federal Policy for the Protection of
Human Subjects (Common Rule) allow researchers and their institu-
tions the option of seeking broad consent from patients for future re-
search uses of their EHR data.9 In contrast with study-specific
consent, broad consent allows institutions to consent patients to fu-
ture, yet-to-be-specified research uses of their individually identifi-
able EHR data.
Broad consent for research use of EHR data has both ethical and
operational implications. Ethically, broad consent must be imple-
mented in a way that reflects patients’ rights to be informed about
and choose how their health information is used, while also consid-
ering the good (beneficence) that may result from the knowledge
obtained from research using information found in EHRs. Opera-
tionally, broad consent may provide a less burdensome option than
study-specific consent while also giving patients more information
and autonomy than using waivers of informed consent. Indeed,
many patients want to be asked about using their personal data and
want some control over its research uses.10–13 Furthermore, EHRs
contain an ever-increasing volume and scope of data, including ge-
netic data and linked data that span care systems and settings. These
important and emergent complexities underscore the ethical, opera-
tional, and scientific need to examine approaches to using broad
consent to ask patients to use their EHR data in research.
Interactive electronic consent (e-consent) applications offer a
promising but understudied informatics solution to conducting
broad consent that is operationally feasible and ethically appropri-
ate. E-consents that deliver consent information via computer and
collect digital signatures are typically lower cost and more scalable
than in-person consents.14,15 E-consents can present federally re-
quired consent information as well as additional information that
patients may want to know. Such additional information may in-
clude examples of study risks, definitions of key terms, or descrip-
tions of technologies and processes that research institutions employ
to protect research data.16 However, simply providing more infor-
mation during the consent process does not necessarily improve the
consent process.17,18 In some cases, providing more information
may produce unintended effects, such as inconsistent decision mak-
ing, perceived coercion, mistrust, decreased understanding, and less
time spent reviewing the information.19 To combat potential unin-
tended effects, e-consents can be designed to allow patients to inter-
actively explore information in a self-guided process that best meets
their individual needs. Indeed, e-consent applications have shown
promise in accommodating the information needs of users at differ-
ent levels.16,20 Some evidence also suggests that multimedia tools al-
low patients to better control the pace of information delivery.21,22
Finally, processes that provide objective information designed to en-
hance trust in research, an important factor in consent,23,24 can also
be easily incorporated into e-consents. Rather than manipulating
patients into making a consent decision, trust enhancements are
intended to underscore factual information and legal protections
and to address patient concerns related to consent processes. There-
fore, in the context of broad consent for patient EHR data sharing
for research, there is value in understanding how different e-consent
designs affect the quality of the consent process. Specifically,
previous studies have not compared e-consents with and without in-
teractive capabilities that deliver additional information that some
patients prefer. Similarly, previous studies have not compared e-con-
sents with and without messages designed to enhance trust in
researchers.
OBJECTIVE
The purpose of this study was to compare the effectiveness of an in-
teractive trust-enhanced e-consent with an interactive-only e-consent
(no trust enhancement) and a standard (no interactivity, no trust en-
hancement) e-consent that asked patients to give broad consent for
future research uses of their EHR data. This study provides a novel
contribution to the biomedical informatics literature in 2 primary
ways. First, this study improves understanding of how different sys-
tems design features affect people’s understanding of and satisfac-
tion with electronically delivered health information. Second, given
increased use of broad consent and increased complexity of a
patient’s health record content, this study provides a more current
understanding of how patients perceive organizational systems and
processes that request access to their health records.
MATERIALS AND METHODS
Procedure
We conducted a randomized trial among a convenience sample of
adults in 4 family medicine practices associated with the University
of Florida academic health center in north-central Florida, United
States. Eligible participants were English-speaking patients 18 years
of age and older making a regularly scheduled medical visit. A re-
search assistant approached eligible participants in clinic waiting
areas and asked patients to consider participating in the study either
before or after their visit. Patients who agreed were given a tablet
computer on which they completed an e-consent that asked them to
include their identifiable EHR data in a “Family Medicine Research
Database” for future, yet-to-be-specified research studies. As re-
quired by our institutional review board to minimize deception,
patients saw an initial screen that indicated the consent process itself
was being studied in addition to the creation of the research data-
base. To maintain realism and minimize participant confusion from
signing multiple consents, the initial screen’s information was brief
and did not require a signature to continue. The research assistant
asked participants to use the tablet independently, though he was
available to assist if patients experienced difficulties using the tech-
nology. Using a prespecified block randomization schedule, the re-
search assistant randomized patients in a 1:1:1 ratio to each of the 3
conditions. Patients were blind to the content and functionality of
the 3 conditions, and thus blind to their assignment.
The research assistant randomly assigned each participant to 1
of 3 e-consent application conditions: standard (no interactivity, no
trust enhancement), interactive only, and interactive trust-enhanced
(Table 1). The e-consent was developed using an iterative design
process involving think-aloud interviews with a community-based
sample of adults to elicit feedback and preferences related to usabil-
ity, content, and potential ethical and privacy concerns.16 The stan-
dard e-consent contained the federally required elements of
informed consent, including an explanation of the purposes of the
research, description of procedures to be followed, descriptions of
any reasonably foreseeable risks or discomforts and benefits, a state-
ment describing the extent to which confidentiality of records will
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be maintained, and a statement that participation in the research data-
base is voluntary. The interactive-only e-consent included all informa-
tion provided in the standard e-consent as well as clickable links to
additional content that our development process suggested some par-
ticipants may want to obtain. This content included examples of pos-
sible future studies, explanations of types of data contained in EHRs,
and definitions of research- or EHR-related terminology. Upon click-
ing these links, the additional information was presented on the same
screen via expanded text boxes that could subsequently be closed
(Figure 1). The interactive trust-enhanced e-consent included all ele-
ments of the standard and interactive-only e-consents as well as trust-
enhanced messages designed to convey trust-relevant attributes of
medical researchers and content related to details on research regula-
tions, researcher training, and data protections both generally and spe-
cific to the health system (Figure 2).
After reviewing the consent information presented in 1 of the 3
randomly assigned e-consent conditions, each participant agreed or
did not agree to allow researchers to access their identifiable past and
future medical or health record information in a Family Medicine Re-
search Database. Immediately after consenting, participants completed
a follow-up survey to assess outcome measures and demographic char-
acteristics (including gender, age, race, ethnicity, and education).
Participants also completed 1-week and 6-month follow-up sur-
veys with the outcome measures repeated. Outcomes from the 6-
month follow-up surveys will be reported once completed. Patients
were compensated $25 for participating in the initial consent pro-
cess and immediate follow-up survey, and $15 for each subsequent
follow-up survey. The procedure was approved by the University of
Florida Institutional Review Board.
Outcome measures
The primary outcomes were satisfaction with the consent decision
and subjective understanding of the consent content. We assessed
participants’ satisfaction with the consent decision using the Satis-
faction with Decision scale, a previously validated assessment of pa-
tient satisfaction with a health care decision.25 The Satisfaction
With Decision scale has been used previously to assess patient satis-
faction with informed consent decisions related to participation in
health research.26–28 We measured participants’ subjective under-
standing of the content presented in the consent application using a
subscale of the Quality of Informed Consent instrument, which was
originally developed to assess subjective and actual understanding of
informed consent in cancer trials.29 The subjective understanding
subscale is intended to measure the degree to which research partici-
pants believe that they are informed about the study, including the
purpose of, risks and potential benefits of, and duration of involve-
ment in the research. The item wording was modified slightly from
the original instrument to reflect the context of consenting to partici-
pate in a research database. For example, the original item “What
the researchers are trying to find out in the clinical trial” was modi-
fied to read “Why the researchers want to use your medical record
information.” Response options remained the same as in the original
instrument and ranged from “I understood this very well” to “I
didn’t understand this at all” on a 5-point Likert-type scale ranging
from 1 (“I didn’t understand this at all”) to 5 (“I understood this
very well”).
Secondary outcomes were objective knowledge of the informed
consent, perceived voluntariness, trust in medical researchers, con-
sent to EHR research uses (yes/no), and engagement with the con-
sent information. We measured objective knowledge by asking
participants to agree or disagree with statements based on factual in-
formation included in all 3 e-consent conditions. We assessed per-
ceived voluntariness using the Decision-Making Control Instrument,
a previously validated tool designed to measure the extent to which
participants view treatment and research decisions as voluntary in
medical settings.30 We measured participants’ attitudes toward
researchers using the Trust in Medical Researchers Scale, a
Table 1. Comparison of content elements between e-consent versions
Consent version
E-consent element Standard Interactive
only
Interactive
trust-enhanced
Federally required elements of informed consent
• Explanation of the purposes of the research; a description of procedures to be followed; a description of
any reasonably foreseeable risks or discomforts to the subject; a description of any benefits to the subject
or to others which may reasonably be expected from the research; a statement describing the extent, if
any, to which confidentiality of records identifying the subject will be maintained; a statement that par-
ticipation is voluntary.
  
Interactive information exploration
• On-demand content including research study examples, explanations of EHR content, and terminology
definitions, delivered interactively via hyperlinked text box call-outs.
• Example text: “Medical Record Number (MRN) Your Medical Record Number or MRN is a unique
number that the University of Florida uses to identify you when you go to the doctor or other healthcare
provider.”
 
Trust-enhanced messages
• Factual messages designed to accurately portray trust-relevant attributes of medical researchers. Message con-
tent includes information such as details on research regulations, researcher training, and data protections.
• Example text: “The computer system that contains your health record here at the University of Florida
has many levels of security and safeguards to keep unauthorized people from seeing your information.”

Consent task (yes or no)
Consent for identifiable past and future medical or health record data to be shared for family medicine re-
search studies.
  
EHR: electronic health record.
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previously validated, 12-item instrument with subscales related to
participant deception and researcher honesty.31 We assessed engage-
ment with the consent application by capturing time spent using the
e-consent. We also measured users’ click activity within the
application.
Other measures
In addition to measuring the outcomes described previously, the par-
ticipant surveys assessed demographics (age, education, gender,
race, and ethnicity).
Sample size
We initially planned for an enrollment of 200 participants per con-
sent condition, for a total of 600 participants. We designed the study
to have 85% power to detect a difference between conditions of 1.1
units for the decisional satisfaction outcome and 2.8 units for the
consent understanding outcome using a 2-sided .025-level test. For
sample size calculations, we defined satisfaction and understanding
as the average of immediate and 1-week follow-up responses.
Statistical analysis
We conducted bivariate analyses to assess relationships between
participant characteristics and outcomes using chi-square tests for
categorical data and 1-way analyses of variance for continuous vari-
ables. For each outcome measured at immediate and 1-week follow-
up (satisfaction, subjective understanding, objective knowledge, per-
ceived voluntariness, and trust in medical researchers), we used lin-
ear mixed models to assess the relationship between consent
condition assignment and the outcome. Each model included a par-
ticipant random effect and fixed effects for consent condition, time
(immediate or 1-week follow-up), participant age, education level,
gender, race, and ethnicity. For outcomes measured only once (con-
sent decision and time spent using the application), we used logistic
and linear regression, respectively, to assess the relationship between
consent condition assignment and these outcomes, controlling for
participant age, education level, gender, race, and ethnicity.
RESULTS
A total of 1242 patients were approached, with 750 (60.4%) agree-
ing to participate. Figure 3 provides an overview of the participant
Figure 1. E-consent example of an opened hyperlink for additional information.
Figure 2. Example of one trust-enhancing message in the interactive trust-enhanced consent application. UF: University of Florida.
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flow. Patients who declined to participate stated either that they
were not interested (n¼387) or that they did not have time to par-
ticipate (n¼105). Additionally, 16 patients either failed to complete
the e-consent or did not complete the immediate follow-up survey
and were excluded from analysis.
The patients included in the analysis were demographically simi-
lar to the underlying population of clinic patients (Table 2). This in-
cluded the percentage female (68.4% in study vs 62.5% in
population), percentage Hispanic or Latino (9.0% vs 5.4%), and
percentage 18-34 years of age (31.7% vs 26.8%), 35-44 years of age
(15.4% vs 16.4%), 45-54 years of age (16.7% vs 16.8%), 55-64
years of age (23.9% vs 19.4%), 65-74 years of age (10.0% vs
13.7%), 75-84 years of age (2.2% vs 5.5%), and 85 years of age or
over (0.1% vs 1.4%). Our study had a higher proportion of patients
who identified as black (43.3% vs 30.6%). Randomization resulted
in a similar distribution of participant demographic characteristics
across the 3 conditions (Table 2).
Across all versions, participants reported moderate to high satis-
faction with consent (mean 4.3 of 5), subjective understanding (79.1
of 100), voluntariness of consent (38.2 of 45), objective knowledge
of the consent (3.5 of 5), and trust in medical researchers (31.9 of
48). On average, participants spent 4.9 minutes reviewing the con-
sent application (median ¼ 2.71 minutes), and 94.3% agreed to
share their health record data. Across the interactive-only and
interactive trust-enhanced versions, 20 (4.1%) participants clicked
at least 1 link for additional information.
In bivariate analysis of immediate follow-up (Table 3), mean satis-
faction with consent was similar across all 3 conditions (standard ¼
4.2, interactive only ¼ 4.2, interactive trust-enhanced ¼ 4.3;
P¼.217), as was mean subjective understanding of consent (80.2,
77.0, and 80.1, respectively; P¼.174). Similarly, objective knowledge
of consent (3.6, 3.4, and 3.6, respectively; P¼.376), perceived volun-
tariness of consent (38.3, 37.7, and 38.6, respectively; P¼.213), trust
in medical researchers (31.8, 31.6, and 32.3, respectively; P¼.661),
consent rate (94.6%, 93.6%, and 94.6%, respectively; P¼.845), and
time spent reviewing the consent (5.23, 4.20, and 5.29 minutes,
respectively; P¼.679) did not significantly differ between conditions
(Table 3). In bivariate analysis of 1-week follow-up for the 624 partic-
ipants who responded, there were also no between-condition differen-
ces in satisfaction with consent (4.5, 4.4, and 4.5, respectively;
P¼.354), subjective understanding of consent (84.0, 83.4, and 83.2,
respectively; P¼.885), objective knowledge of consent (4.1, 4.0, and
3.9, respectively; P¼.503), perceived voluntariness of consent (38.2,
37.9, and 38.2, respectively; P¼.830), and trust in medical research-
ers (33.0, 33.8, and 33.8, respectively; P¼.480).
Differences between conditions were estimated using a chi-
square test for consent decision and analysis of variance for all other
outcomes.
Assessed for eligibility (N=1,242) 
Excluded (n=492) 
♦ Not meeting inclusion criteria (N=0) 
♦ Declined to participate (N=492) 
• Analyzed at immediate 
follow-up (N=243) 
Randomized (N=750) 
Allocated to standard consent 
application  
(N=250) 
• Analyzed at immediate 
follow-up (N=248) 
• Analyzed at immediate 
follow-up (N=243) 
Allocated to interactive only
consent application  
(N=250) 
Allocated to interactive trust-
enhanced consent application 
(N=250) 
Discontinued intervention (N=1) 
Lost to immediate follow-up (N=6) 
Lost to 1-week follow-up (N=36) 
Discontinued intervention (N=0) 
Lost to immediate follow-up (N=2) 
Lost to 1-week follow-up (N=34) 
Discontinued intervention (N=1) 
Lost to immediate follow-up (N=6) 
Lost to 1-week follow-up (N=40) 
Figure 3. Trial flow diagram describing randomization, allocation, follow-up, and analysis.
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Our multivariable modeling also indicated no between-condition
differences in the primary or secondary outcomes (Table 4). How-
ever, we did observe statistically significant relationships between
several demographic characteristics and the consent outcomes. In
particular, when compared with participants with less than a high
school education, participants with some college education (B ¼
0.16, P¼.011) or a bachelor’s degree (B ¼ 0.21, P¼.004) reported
significantly higher satisfaction with the consent. Also, when
compared with participants with less than a high school education,
participants with some college education (B ¼ 4.88, P¼.03) or a
bachelor’s degree (B ¼ 5.11, P¼.045) reported significantly higher
subjective understanding of the consent. Similarly, participants with
some college education (B ¼ 0.49, P¼.0002), a bachelor’s degree
(B ¼ 0.86, P<.0001), or a master’s, professional, or doctorate de-
gree (B ¼ 1.03, P<.0001) reported significantly higher objective
knowledge of the consent compared with participants with less than
a high school education. Also, participants with some college educa-
tion (B ¼ 3.50, P<.0001), a bachelor’s degree (B ¼ 4.69,
P<.0001), or a master’s, professional or doctorate degree (B ¼
5.68, P<.0001) each reported significantly higher perceived volun-
tariness compared with participants with less than a high school ed-
ucation. Similarly, when compared with participants with less than
a high school education, participants in higher education groups, in-
cluding some college education (B ¼ 2.03, P¼.031), a bachelor’s
degree (B ¼ 2.82 P¼.009), or a master’s, professional or doctorate
degree (B ¼ 3.98, P<.0001), reported higher trust in medical
researchers. Compared with those with less than a high school edu-
cation, participants in higher education groups, including some
college education (B ¼ –66.32, P¼.020), a bachelor’s degree (B ¼
–87.94, P¼.007), or a master’s, professional or doctorate degree
(B ¼ –129.94, P¼.002), spent less time reviewing the consent
application.
Table 2. Participant demographic characteristics by e-consent condition (N¼ 734)
Standard
(n¼ 243)
Interactive Only
(n¼ 248)
Interactive Trust-Enhanced
(n¼ 243)
P Value
Age, ya 46.3 6 16.8 45.2 6 15.3 45.4 6 16.0 .716
Gender .486
Female 161 (66.3) 168 (67.7) 173 (71.2)
Male 82 (33.7) 80 (32.3) 70 (28.8)
Race .309
White 123 (50.6) 115 (46.4) 100 (41.2)
Black or African-American 96 (39.5) 109 (44.0) 113 (46.5)
Asian 3 (1.2) 3 (1.2) 9 (3.7)
American Indian or Alaska Native 1 (0.4) 2 (0.8) 1 (0.4)
Native Hawaiian or Pacific Islander 0 (0.0) 1 (0.4) 1 (0.4)
Other single race 10 (4.1) 9 (3.6) 7 (2.9)
Multiple race 10 (4.1) 9 (3.6) 12 (4.9)
Ethnicity .402
Hispanic 25 (10.3) 24 (9.7) 17 (7.0)
Not Hispanic 218 (89.7) 224 (90.3) 226 (93.0)
Education .127
Less than high school 23 (9.5) 20 (8.1) 29 (11.9)
High school graduate or GED 85 (35.0) 98 (39.5) 66 (27.2)
Some college 77 (31.7) 68 (27.4) 89 (36.6)
Bachelor’s degree 37 (15.2) 38 (15.3) 31 (12.8)
Master’s, professional, or doctorate degree 21 (8.6) 24 (9.7) 28 (11.5)
Values are mean 6 SD or n (%). Differences between conditions were assessed using analyses of variance for age and chi-square tests for all other variables.
an¼ 732 due to missing data.
Table 3. Outcomes at immediate follow-up by e-consent condition
Standard
(n¼ 243)
Interactive Only
(n¼ 248)
Interactive Trust-Enhanced
(n¼ 243)
P Value
Primary outcomes
Satisfaction with consent (1-5) 4.23 6 0.74 4.23 6 0.69 4.336 0.66 .217
Subjective understanding of consent (0-100) 80.23 6 20.92 76.96 6 23.73 80.11 6 21.13 .174
Secondary outcomes
Objective knowledge about consent (0-5) 3.58 6 1.31 3.42 6 1.49 3.566 1.31 .376
Perceived voluntariness of consent (9-45) 38.29 6 5.45 37.65 6 6.91 38.58 6 5.68 .213
Trust in medical researchers (0-48) 31.75 6 8.32 31.60 6 8.59 32.27 6 8.69 .661
Consent decision (agree/disagree)a 229 (94.6) 232 (93.6) 227 (94.6) .845
Time spent reviewing the consent, min 5.23 6 9.37 4.20 6 6.67 5.296 8.43 .679
Values are mean 6 SD or n (%).
an¼ 730 for consent decision due to missing data (242 for standard, 248 for interactive only, and 240 for interactive trust-enhanced).
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When compared with white participants, black participants
reported significantly lower satisfaction (B ¼ –0.24, P<.0001),
lower subjective understanding (B ¼ –6.32, P<.0001), lower objec-
tive knowledge (B ¼ –0.66, P<.0001), lower perceived voluntari-
ness (B ¼ –3.35, P<.0001), lower trust in medical researchers (B ¼
–5.58, P<.0001), and spent more time using the e-consent applica-
tion (B ¼ 38.62, P¼.026). Similarly, when compared with white
participants, participants of races other than black or white reported
significantly lower subjective understanding (B ¼ –5.20, P¼.014),
lower objective knowledge (B ¼ –0.55, P<.0001), lower perceived
voluntariness (B ¼ –1.85, P¼.001), lower trust in medical research-
ers (B ¼ –4.22, P<.0001), and more time spent using the e-consent
application (B ¼ 77.20, P¼.004). Also, when compared with non-
Hispanic participants, Hispanic participants reported lower trust in
medical researchers (B ¼ –2.33, P¼.013) and more time spent using
the e-consent application (B ¼ 66.43, P¼.018).
Finally, we conducted exploratory bivariate analyses of outcomes
between conditions for racial minority (i.e. all races except white)
participants only (n¼396). Among minority participants, statistically
significant differences were observed between consent conditions for
perceived voluntariness (standard ¼ 36.3, interactive only ¼ 35.3, in-
teractive trust-enhanced ¼ 37.4; P¼.019) and objective knowledge
of consent information (3.1, 2.9, and 3.4, respectively; P¼.046).
These differences were marginally significant at 1-week follow-up for
perceived voluntariness (standard ¼ 36.1, interactive only ¼ 35.9, in-
teractive trust-enhanced ¼ 37.5; P¼.057) and not significant for ob-
jective knowledge (3.7, 3.6, and 3.8, respectively; P¼.591).
DISCUSSION
The primary results of our randomized trial of 3 e-consent
approaches for health record sharing indicated no effect of interac-
tivity alone or interactivity with trust enhancement on participant
satisfaction with or subjective understanding of the consent. Simi-
larly, we found no between-condition differences for our secondary
outcomes of objective knowledge of consent information, perceived
voluntariness, trust in medical researchers, consent decision, and
time spent using the application. Offering interactive features and
trust-enhancing messages to standard consent information did not
improve participants’ consent experiences. At the same time, the ad-
dition of interactive features and trust enhancement messages did
not appear to detract from the average participant’s consent experi-
ence, as we also found no negative effects of these features on con-
sent outcomes. Furthermore, given that only 4.1% of participants
who were offered interactive features chose to click on 1 or more
hyperlinks, these findings suggest that many people, when asked in a
primary care setting to share their health records for research, are
not motivated to seek additional information.
We also found that a large majority of participants (94.3%)
across all 3 e-consent conditions agreed to share their health records
for research. This finding echoes previous research indicating high
levels of willingness in the general population to share individually
identifiable health record information for future research.32–35 Addi-
tionally, participants in this study, regardless of consent condition,
demonstrated high rates of satisfaction with the consent process,
perceived voluntariness of the process, and trust in medical research-
ers. Moreover, the median time spent reviewing the application was
only 2.71 minutes. Together, these findings suggest that most
patients consenting to share their health records for research in the
context of their primary care provider’s office do not require signifi-
cant time or information beyond standard consent information to
feel satisfied, informed, and in control of their decision to share their
health records.
The findings of this study have implications for policies and
practices surrounding broad consent to share protected health infor-
mation for research. On one hand, our results suggest limited benefit
to healthcare organizations in developing e-consent systems with ad-
ditional content and trust-enhancing messages that are interactively
delivered. On the other hand, if costs are relatively low for develop-
ing such systems (eg, if an organization already has an EHR with
e-consent functionality), healthcare systems might consider adding
interactive or trust-enhancing elements without harming patient sat-
isfaction or understanding. Furthermore, most patients in our study
spent minimal time reviewing and completing the e-consent, suggest-
ing it is relatively easy to incorporate enhanced e-consent features
into primary care clinic workflows. If it is relatively low-cost to de-
velop and implement, an enhanced e-consent may also add value by
better meeting the needs of patient subgroups who do desire more
information when making a consent decision. Indeed, our prior
qualitative study on patient perceptions of using an interactive e-
consent application reinforced the notion that some patients are
higher information seekers than others and, at least when asked hy-
pothetically, desire an interactive e-consent that offers additional in-
formation and trust-enhancing messages.16 Overall, healthcare
organizations will need to carefully weigh this and other existing ev-
idence, from both ethical and operational perspectives, of the value
of implementing broad consent and different system design options.
Moreover, consistent with previous work,35–39 the present study
clearly indicated differences in the consent experiences of racial and
ethnic minority participants and participants with lower education.
Participants in these groups, on average, spent significantly more
time reviewing the e-consent, yet reported lower scores on several
important outcome measures. While offering additional information
via interactivity and trust-enhancing messages did not improve these
participants’ experiences, our findings do suggest the potential value
of other novel approaches to consent that ensure vulnerable groups
are equally informed when consenting to research. For example, in
exploratory analysis on our subgroup of racial minority participants,
we found significant differences between consent conditions at imme-
diate follow-up for perceived voluntariness and objective knowledge.
Interestingly, these differences indicate lower perceived voluntari-
ness and objective knowledge for racial minority participants allo-
cated to the interactive-only condition relative to the standard
consent and the interactive trust-enhanced consent. One potential
explanation for these findings is an unfavorable effect of interactive
features alone in the absence of trust messaging among some partici-
pants. Specifically, among patients such as racial minorities who
may already be wary of research motivations and practices,40–42 the
added volume of information presented in the interactive-only con-
sent may have been overwhelming, resulting in reduced knowledge
and perceptions of voluntariness. The presence of trust messaging in
the interactive trust-enhanced consent may have then served to miti-
gate any negative effects of the additional information presented.
Given the exploratory nature of these ancillary results, they are not
definitive but may inform hypotheses for future research on develop-
ing improved e-consent processes—especially research that focuses
on patient subgroups who report poorer experiences with consent pro-
cesses and research in general. Previous work has identified ways for
researchers to increase satisfaction and comprehension of informed
consent among minority patients, including increased direct contact
with study investigators, availability of take-home materials related
to the study, and the ability for potential participants to talk to
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someone currently participating in the study.43–45 To our knowl-
edge, these strategies have not been tested in the context of broad
consent, but academic health centers may consider incorporating
these strategies as they design and evaluate broad e-consent tools.
The strengths of this study include its randomized, controlled design
and comprehensive set of important consent outcomes. The e-consent
intervention functionality and content were developed based on federal
requirements for informed consent and an iterative design process with
significant patient feedback.16 Also, this study enrolled a relatively large
and diverse sample of patients in the context of a large academic health
center’s family medicine clinics. Furthermore, the study implemented
and compared 3 versions of an actual research consent, rather than in-
volving hypothetical, nonbinding consent scenarios.46–48
Perhaps the primary limitation of this study is that nearly 40%
of clinic patients approached by a research assistant to participate in
our e-consent study declined to do so. Patients typically declined due
to a reported lack of time to complete the full study protocol, which
included an extensive survey about their consent experience. How-
ever, as has been observed in other studies, we expect that many
more patients would actively make a consent decision if the process
were fully integrated into clinic workflows and systems.49 In our
study, nearly all patients who took the time to participate (94.3%)
agreed to share their health record information. Therefore, this limi-
tation should not be viewed as a weakness of potential implementa-
tion nor of patients’ willingness to provide broad consent. Instead,
this, along with the fact that the study was conducted in 4 clinics in
a single health center, may limit the generalizability of our results to
the broader population of adult patients seeking primary care. Par-
tially mitigating this limitation, our participant sample was demo-
graphically similar to the underlying patient population at our
institution. Moreover, our participant sample was diverse in terms
of gender, race, and education, including a significant number of
women, black/African-American patients, and patients with less
than a college education. Therefore, given known barriers to appro-
priate and effective research involving vulnerable patients, these
characteristics of our sample composition strengthened our contri-
bution to knowledge about consent among these groups.
Our study is also limited by the exclusion of non–English-speak-
ing participants. Future work should explore broad consent pro-
cesses among patients from different cultural backgrounds, who
may face additional barriers to comprehension, satisfaction, and
voluntariness. Also, our study analysis is limited by the large number
of hypothesis tests over our primary, secondary, and exploratory
analyses. This increases the likelihood that, over our multiple hy-
pothesis tests, we inferred statistically significant results that were
simply due to chance. Also, the instruments we used to assess the
primary outcomes of decisional satisfaction and subjective under-
standing have not been validated for use in the specific context of
broad consent. Based on our review of the literature, these repre-
sented the best existing instruments for assessing our consent out-
comes of interest. Future work should seek to advance measurement
related to broad consent and consent for EHR research use by devel-
oping and validating new instruments.
Finally, our findings may not be applicable to incorporating in-
teractivity or trust enhancements into clinical consents or other
types of research consents. Specifically, in light of our findings along
with previous evidence that most people are willing to consent to re-
search uses of their identifiable personal health record informa-
tion,33–35 patients may have different information needs when
considering participation in research perceived as riskier or more
complex. Future work could examine whether incorporating
interactive information exploration or trust enhancements into risk-
ier or more complex consent scenarios adds more value. Also, future
work could focus on the effect of e-consent enhancements on certain
subpopulations, such as racial and ethnic minorities, who are histor-
ically less willing to agree to participate in research.40,42
CONCLUSION
In the context of using an electronic consent application to consider
sharing individually identifiable health records for future research, we
found that a large majority of patients were willing to share and
reported positive consent experiences. However, incorporating optional
additional information and messages designed to enhance trust in the re-
search process did not improve consent experiences. To help improve
the consent experiences of racial and ethnic minority participants and
those with lower educational attainment, it may be valuable for future
research to explore other novel consent technologies and processes. As
EHRs’ content becomes more expansive and includes new types of
data, these findings provide new knowledge on patients’ current accep-
tance of consent processes for EHR data sharing. Moreover, these find-
ings provide important insights on the limits of conceptually supported
design features in actually enhancing patients’ consent experiences.
FUNDING
This work was supported by Eunice Kennedy Shriver National Insti-
tute of Child Health and Human Development grant number
R01HD086700-03 to the University of Florida (Principal Investiga-
tors: Drs. Harle, Moseley, and Mainous).
AUTHOR CONTRIBUTIONS
CAH was responsible for the study concept and design, overseeing
data collection, analysis and interpretation of the data, and initial
draft of the manuscript. EHG was responsible for analysis and inter-
pretation of the data and initial drafting of the manuscript. KPR was
responsible for design, collection, analysis, and interpretation of the
data. JLK, AGMIII, KWG, BB, and REM were responsible for the
study concept and design. BB also oversaw data analysis. REM also
oversaw data collection. All authors approved the final manuscript.
ACKNOWLEDGMENTS
The authors acknowledge the contributions of the University of Florida De-
partment of Community Health and Family Medicine, Ben Rooks, and the
Department’s clinic staff for supporting the study. The authors also acknowl-
edge the Regenstrief Institute software engineering team for its contributions
to developing the e-consent application.
CONFLICT OF INTEREST STATEMENT
None declared.
REFERENCES
1. Hersh WR. Adding value to the electronic health record through second-
ary use of data for quality assurance, research, and surveillance. Am J
Manag Care 2007; 81: 126–8.
2. Ross M, Wei W, Ohno-Machado L. “Big data” and the electronic health
record. Yearb Med Inform 2014; 9 (1): 97.
628 Journal of the American Medical Informatics Association, 2019, Vol. 26, No. 7
3. Luo J, Wu M, Gopukumar D, et al. Big data application in biomedical research
and health care: a literature review.Biomed Inform Insights 2016; 8: S31559.
4. Embi PJ, Payne PR. Evidence generating medicine: redefining the research-
practice relationship to complete the evidence cycle. Med Care 2013; 51:
S87–91.
5. McGlynn EA, Lieu TA, Durham ML, et al. Developing a data infrastruc-
ture for a learning health system: the PORTAL network. J Am Med In-
form Assoc 2014; 21 (4): 596–601.
6. Thadani SR, Weng C, Bigger JT, et al. Electronic screening improves effi-
ciency in clinical trial recruitment. J Am Med Inform Assoc 2009; 16 (6):
869–73.
7. Fleurence RL, Curtis LH, Califf RM, et al. Launching PCORnet, a na-
tional patient-centered clinical research network. J Am Med Inform Assoc
2014; 21 (4): 578–82.
8. Hernandez AF, Fleurence RL, Rothman RL. The ADAPTABLE trial and
PCORnet: shining light on a new research paradigm. Ann Intern Med
2015; 163 (8): 635–6.
9. Federal Policy for the Protection of Human Subjects, 45 CFR part 46 Office
for Human Research Protections (OHRP), ed. 2018; Vol 82, No. 12.
10. Damschroder LJ, Pritts JL, Neblo MA, Kalarickal RJ, Creswell JW, Hay-
ward RA. Patients, privacy and trust: patients’ willingness to allow research-
ers to access their medical records. Soc Sci Med 2007; 64 (1): 223–35.
11. Donald JW, Karim K, Kalpana N, Charlie G, Anne MH. Patients’ consent
preferences for research uses of information in electronic medical records:
interview and survey data. BMJ 2003; 326 (7385): 373–376.
12. Caine K, Hanania R. Patients want granular privacy control over health
information in electronic medical records. J Am Med Inform Assoc 2013;
20 (1): 7–15.
13. Whiddett R, Hunter I, Engelbrecht J, Handy J. Patients’ attitudes towards
sharing their health information. Int J Med Inform 2006; 75 (7): 530–41.
14. Marshall EA, Oates JC, Shoaibi A, et al. A population-based approach for
implementing change from opt-out to opt-in research permissions. PLoS
One 2017; 12 (4): e0168223.
15. Sanderson IC, Obeid JS, Madathil KC, et al. Managing clinical research
permissions electronically: a novel approach to enhancing recruitment
and managing consents. Clin Trials 2013; 10 (4): 604–11.
16. Harle CA, Golembiewski EH, Rahmanian KP, et al. Patient preferences
toward an interactive e-consent application for research using electronic
health records. J AmMed Inform Assoc 2018; 25 (3): 360–8.
17. Manson N, O’Neill O. Rethinking Informed Consent in Bioethics. Cam-
bridge, UK: Cambridge University Press; 2007.
18. Falagas M, Korbila I, Giannopoulou K, et al. Informed consent: how much
and what do patients understand? Am J Surg 2009; 198 (3): 420–35.
19. Schenker Y, Meisel A. Informed consent in clinical care: practical consid-
erations in the effort to achieve ethical goals. JAMA 2011; 305 (11):
1130–1.
20. Rowbotham MC, Astin J, Greene K, et al. Interactive informed consent:
randomized comparison with paper consents. PLoS One 2013; 8 (3):
e58603.
21. Jimison HB, Sher PP, Appleyard R, et al. The use of multimedia in the in-
formed consent process. J AmMed Inform Assoc 1998; 5 (3): 245–56.
22. Synnot A, Ryan R, Prictor M, et al. Audio-visual presentation of informa-
tion for informed consent for participation in clinical trials. Cochrane
Database Syst Rev 2014; 5 (CD003717): 1–141.
23. Zhang Z, Bickmore TW, Paasche-Orlow MK. Perceived organizational
affiliation and its effects on patient trust: role modeling with embodied
conversational agents. Patient Educ Couns 2017; 100 (9): 1730–7.
24. Kneipp SM, Lutz BJ, Means D. Reasons for enrollment, the informed con-
sent process, and trust among low-income women participating in a com-
munity-based participatory research study. Public Health Nurs 2009; 26
(4): 362–9.
25. Holmes-Rovner M, Kroll J, Schmitt N, et al. Patient satisfaction with
health care decisions: the satisfaction with decision scale. Med Decis Mak-
ing 1996; 16 (1): 58–64.
26. Fink AS, Prochazka AV, Henderson WG, et al. Enhancement of surgical
informed consent by addition of repeat back: a multicenter, randomized
controlled clinical trial. Ann Surg 2010; 252 (1): 27–36.
27. Stryker JE, Wray RJ, Emmons KM, et al. Understanding the decisions of
cancer clinical trial participants to enter research studies: factors
associated with informed consent, patient satisfaction, and decisional re-
gret. Patient Educ Couns 2006; 63 (1–2): 104–9.
28. Simon CM, Siminoff LA, Kodish ED, et al. Comparison of the informed
consent process for randomized clinical trials in pediatric and adult oncol-
ogy. J Clin Oncol 2004; 22 (13): 2708–17.
29. Joffe S, Cook EF, Cleary PD, et al. Quality of informed consent: a new
measure of understanding among research subjects. J Natl Cancer Inst
2001; 93 (2): 139–47.
30. Miller VA, Ittenbach RF, Harris D, et al. The decision making control instru-
ment to assess voluntary consent.MedDecisMaking 2011; 31 (5): 730–41.
31. Mainous AG, Smith DW, Geesey ME, et al. Development of a measure to
assess patient trust in medical researchers. Ann Fam Med 2006; 4 (3):
247–52.
32. Weitzman ER, Kaci L, Mandl KD. Sharing medical data for health re-
search: the early personal health record experience. J Med Internet Res
2010; 12 (2): e14.
33. Willison DJ, Schwartz L, Abelson J, et al. Alternatives to project-specific
consent for access to personal information for health research: what is the
opinion of the Canadian public? J Am Med Inform Assoc 2007; 14 (6):
706–12.
34. Willison DJ, Steeves V, Charles C, et al. Consent for use of personal infor-
mation for health research: do people with potentially stigmatizing health
conditions and the general public differ in their opinions? BMC Med
Ethics 2009; 10 (1): 10.
35. Grande D, Mitra N, Shah A, et al. Public preferences about secondary
uses of electronic health information. JAMA Intern Med 2013; 173 (19):
1798–806.
36. Dimitropoulos L, Patel V, Scheffler S, et al. Public attitudes toward health
information exchange: perceived benefits and concerns. Am J Manag Care
2011; 17 (Spec No 12): SP111–6.
37. Kim KK, Sankar P, Wilson MD, et al. Factors affecting willingness to
share electronic health data among California consumers. BMC Med
Ethics 2017; 18 (1): 25.
38. Enama ME, Hu Z, Gordon I, et al. Randomization to standard and con-
cise informed consent forms: development of evidence-based consent prac-
tices. Contemp Clin Trials 2012; 33 (5): 895–902.
39. Stunkel L, Benson M, McLellan L, et al. Comprehension and informed
consent: assessing the effect of a short consent form. IRB 2010; 32 (4): 1–9.
40. Corbie-Smith G, Thomas SB, St. George DMM. Distrust, race, and re-
search. Arch Intern Med 2002; 162 (21): 2458–63.
41. Bussey-Jones J, Garrett J, Henderson G, et al. The role of race and trust in tis-
sue/blood donation for genetic research.GenetMed 2010; 12 (2): 116–21.
42. Corbie-Smith G, Thomas S, Williams M, et al. Attitudes and beliefs of
African-Americans toward participation in medical research. J Gen Intern
Med 1999; 14 (9): 537–46.
43. Quinn SC, Garza MA, Butler J, et al. Improving informed consent with
minority participants: results from researcher and community surveys. J
Empir Res Hum Res Ethics 2012; 7 (5): 44–55.
44. Cohn E, Larson E. Improving participant comprehension in the informed
consent process. J Nurs Scholarsh 2007; 39 (3): 273–80.
45. Flory J, Emanuel E. Interventions to improve research participants’ under-
standing in informed consent for research: a systematic review. JAMA
2004; 292 (13): 1593–601.
46. Agre P, Rapkin B. Improving informed consent: a comparison of 4 consent
tools. IRB 2003; 25 (6): 1–7.
47. Karunaratne AS, Korenman SG, Thomas SL, et al. Improving communica-
tion when seeking informed consent: a randomised controlled study of a
computer-based method for providing information to prospective clinical
trial participants. Med J Aust 2010; 192 (7): 388–92.
48. Harmell AL, Palmer BW, Jeste DV. Preliminary study of a web-based tool
for enhancing the informed consent process in schizophrenia research.
Schizophr Res 2012; 141 (2–3): 247–50.
49. Iafrate PI, Lipori GP, Harle CA, et al. Consent2Share: an integrated broad
consenting process for re-contacting potential study subjects. J Clin Transl
Res 2016; 2 (4): 1.
Journal of the American Medical Informatics Association, 2019, Vol. 26, No. 7 629
